We used siRNA to suppress the SPOP expression in prostate cancer cells, and performed a mass spectrometry analysis on the lysates from these cells to determine which proteins have an altered expression upon the depletion of SPOP. The gene discussed is SPOP; the disease is prostate carcinoma.